These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nectin-1 expression in the normal and neoplastic human uterine cervix. Guzman G, Oh S, Shukla D, Valyi-Nagy T. Arch Pathol Lab Med; 2006 Aug; 130(8):1193-5. PubMed ID: 16879022 [Abstract] [Full Text] [Related]
3. [The location of keratins 17 and 8 in the metaplastic proliferates of the endocervix]. Bulanova EA, Chipysheva TA, Ermilova VD, Gel'shteĭn VI. Arkh Patol; 1994 Aug; 56(5):69-73. PubMed ID: 7535046 [Abstract] [Full Text] [Related]
5. [Distribution of lectin-receptors in normal, dysplastic and neoplastic cervical epithelium]. Li ZH. Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):284-7. PubMed ID: 1813164 [Abstract] [Full Text] [Related]
7. Immunohistochemical detection of Ca antigen in normal, dysplastic and neoplastic squamous epithelia of the human uterine cervix. Lloyd JM, O'Dowd T, Driver M, Tee DE. J Clin Pathol; 1984 Jan; 37(1):14-9. PubMed ID: 6368596 [Abstract] [Full Text] [Related]
8. [Microdensitometric analysis of the RNA content and distribution in the cellular elements of the epithelial layer of the cervix uteri in the process of dysplastic transformation]. Semenov SN, Bykov EG, Kozachenko VP. Akush Ginekol (Mosk); 1978 Oct; (10):62-3. PubMed ID: 717680 [No Abstract] [Full Text] [Related]
10. Lectin binding to normal, dysplastic, and neoplastic cervical epithelium. Bychkov V, Toto PD. Am J Clin Pathol; 1986 May; 85(5):542-7. PubMed ID: 3706196 [Abstract] [Full Text] [Related]
11. [Expression of the protein marker p16INK4a in the cervix uteri cancer]. Volgareva GM, Zavalishina LE, Frank GA, Andreeva IuIu, Petrov AN, Kiselev FL, Spitkovskiĭ DD. Arkh Patol; 2002 May; 64(1):22-4. PubMed ID: 11889694 [Abstract] [Full Text] [Related]
13. Immunohistochemical identification of Langerhans cells in normal epithelium and in epithelial lesions of the uterine cervix. Puts JJ, Moesker O, de Waal RM, Kenemans P, Vooijs GP, Ramaekers FC. Int J Gynecol Pathol; 1986 May; 5(2):151-62. PubMed ID: 3087896 [Abstract] [Full Text] [Related]
15. Experience with the Oxford tumour marker in uterine cervical lesions. Beltrami CA, Di Loreto C, De Nictolis M, Stramazzotti D. Appl Pathol; 1984 May; 2(1):39-42. PubMed ID: 6395880 [Abstract] [Full Text] [Related]
17. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium. Maruo T, Yamasaki M, Ladines-Llave CA, Mochizuki M. Cancer; 1992 Mar 01; 69(5):1182-7. PubMed ID: 1739918 [Abstract] [Full Text] [Related]
18. [The expression of cytokeratin No. 17 in squamous cell cancer of the cervix uteri: an immunohistochemical study of 19 cases]. Petrov SV, Raĭkhlin NT. Vopr Onkol; 1992 Mar 01; 38(7):797-805. PubMed ID: 1284457 [Abstract] [Full Text] [Related]
19. Utility of proliferation-associated marker MIB-1 in evaluating lesions of the uterine cervix. Mittal K. Adv Anat Pathol; 1999 Jul 01; 6(4):177-85. PubMed ID: 10410171 [Abstract] [Full Text] [Related]
20. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV. Mittal KR, Lin O, Chan W, Goswami S, Demopoulos RI. Gynecol Oncol; 1995 Sep 01; 58(3):289-94. PubMed ID: 7672694 [Abstract] [Full Text] [Related] Page: [Next] [New Search]